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Abstract. The membrane topology of the high affinity, 
Na+-coupled L-glutamate/L-aspartate transporter 
(GLAST-1) of the central nervous system has been de- 
termined. Truncated GLAST-1 cDNA constructs en- 
coding protein fragments with an increasing number of 
hydrophobic regions were fused to a cDNA encoding a 
reporter peptide with two N-glycosylation sites. The re- 
spective cRNA chimeras were translated in vitro and in 
vivo in Xenopus oocytes. Posttranslational N-glycosyla- 
tion of the two reporter consensus sites monitors the 
number, size, and orientation of membrane-spanning 
domains. The results of our experiments suggest a 
novel 10-transmembrane domain topology of GLAST-1, 
a representative of the L-glutamate neurotransmitter 
transporter family, with its NH2 and COOH termini on 
the cytoplasmic side, six NH2-terminal hydrophobic 
transmembrane a-helices, and four COOH-terminal 
short hydrophobic domains spanning the bilayer pre- 
dicted as 13-sheets. 
-Glutamate  transporters  are  integral  membrane  gly- 
coproteins.  They  are  concentrated  in  the  plasma 
membrane of glial cells and in nerve terminals sur- 
rounding the synaptic cleft, where they regulate the con- 
centration of the excitatory neurotransmitter L-glutamate 
in the cleft of excitatory synapses (Flott and Seifert, 1991). 
Two different families of neurotransmitter transporters 
have been identified. The Na+-/Cl--coupled GAT-1 trans- 
porter  family includes  the  3,-aminobutyrate  transporter 
(Guastella et al., 1990), the noradrenaline (Pacholczyk et al., 
1991), dopamine (Shimada, et al 1991), serotonin (Blakely 
et  al.,  1991),  glycine (Smith et  al.,  1992),  and  L-proline 
transporters (Fremeau et al., 1992). They share a 12-mem- 
brane-spanning domain topology (Uhl, 1992) with the car- 
riers of the Na+-dependent glucose transporter (SGLT-1) 
family (Hediger et al., 1987). 
The  recently discovered  Na+-dependent  L-glutamate 
transporter GLAST-11 (Storck et al., 1992), GLT-1 (Pines 
et  al.,  1992),  EAAC-1  (Kanai  and  Hediger,  1992),  and 
EAAT-4, a  Na÷/Cl--dependent member isolated by ho- 
mology screening (Fairman et al.,  1995),  form a  second 
family of excitatory neurotransmitter transporters in the 
central  nervous  system.  They  catalyze  an  electrogenic 
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cotransport of L-glutamate and two or three Na + ions cou- 
pled to the counterflow of one K ÷ and probably one OH- 
ion (Bouvier et al., 1992; Kl6ckner et al., 1993, 1994; Kanai 
et al., 1995). The members of this family show an overall 
amino acid identity of about 50%. The L-glutamate trans- 
porters are neither related to the GAT-1 nor to the SGLT-1 
transporter family but show significant similarities (27-37 %) 
to the neutral amino acid transporter ASCT-1  (Arizza et 
al., 1993) or SAAT (Shafqat et al., 1993),  to the proton- 
coupled L-glutamate transporter proteins GLTP of Escheri- 
chia  coli  (Tolner  et  al.,  1992b)  and  GLTT  of Bacillus 
stearothermophilus (Tolner et al.,  1992a),  and to the C4- 
dicarboxylate carrier DCTA of Rhizobium  meliloti  (En- 
gelke et al., 1989). 
Three  different  transmembrane  topology  models  of 
GLAST-1 (Storck et al., 1992), GLT-1 (Pines et al., 1992), 
and EAAC-1  (Kanai and Hediger, 1992) have been pro- 
posed, although the hydropathy plots are almost identical. 
In the NHz-terminal half, they have six hydrophobic mem- 
brane-spanning  a-helices  and  an  extended  extracellular 
loop (extramembrane region 4 [EMR4]) between transmem- 
brane domain 3 (TMD3) and 4 (TMD4) with two N-glyco- 
sylation sites in common. For GLAST-1, we have shown 
by peptide sequencing (Schulte and Stoffel, 1995) and site- 
directed mutagenesis (Conradt et al., 1995) that two out of 
three putative N-glycosylation sites at N206 and N216 are 
glycosylated. The membrane topology of the highly con- 
served COOH-terminal domain of about 150 residues has 
been discussed controversially on the basis of their ambig- 
uous hydropathy plot. 
Pivotal  for understanding the  structure-function rela- 
tionship and the regulation of the L-glutamate transporter 
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ogy of these important transporters of excitatory neuro- 
transmitters in the central nervous system. In the present 
study, we investigated the glutamate transporter topology 
by the "reporter glycosylation scanning" strategy. This di- 
rect biochemical method, which has been used successfully 
for topological mapping of polytopic KDEL-receptor  (Singh 
et al., 1993), analyzes the glycosylation sensitivity of a to- 
pological  neutral reporter epitope placed in positions  to 
bracket the proposed transmembrane domains.  This  ap- 
proach was complemented by the determination of the use 
of N-linked glycosylation sites introduced in the wild-type 
transporter and by immunofluorescent studies. 
Our  results  with the  GLAST-1  glutamate transporter 
demonstrate  six  membrane-spanning  domains  of  most 
likely a-helical structure (TMD 1-6) in the NH2-terminal 
part of the protein and four shorter transmembrane seg- 
ments (TMD 7-10) in the COOH-terminal part of the pro- 
tein, with both termini residing on the cytoplasmic surface 
of the plasma membrane. We suggest that this novel 10- 
TMD topology might be common to the other members of 
the L-glutamate transporter family. 
Materials and Methods 
Construction  of Undeleted and Deleted Fusion Proteins 
The plasmid pSP64-GLAST (Storck et aL, 1992) served as template in the 
creation of the fusion proteins. The AccI site in the multiple cloning site of 
pSP64-GLAST was eliminated by a Sail digestion, filling in reaction with 
Klenow enzyme and blunt-end religation with T4 ligase (Boehringer Mann- 
heim Corp., Indianapolis, IN). The DNA fragment coding for the glycosy- 
lation reporter (D172-R228 of GLAST-1) was amplified in a PCR carry- 
ing in frame at the Y-end a SacI and XhoI and at the T-end a TAG stop 
codon and SacI restriction site. The reporter fragment was cloned into 
the Sacl site downstream of the GLAST-1 gene in pSP64-GLAST re- 
suiting in pSP64-GLAST-REP. Fusions of transporter fragments to the 
glycosylation reporter segment were achieved by replacing COOH-termi- 
nal domains of the full-length GLAST-1 cDNA in pSP64-GLAST-REP 
between a suitable 5' restriction site and the XhoI site 3' in front of the 
glycosylation reporter with PCR-generated DNA cassettes, coding for re- 
spective COOH-terminal parts of graded NH2-terminal stretches of the 
transporter. A  NheI 5' restriction site in the GLAST-I gene was used for 
fusion proteins G-E77, G-R122, and G-P233; KpnI was used for G-$273, 
G-Q313, G-N344, G-Q354, and G-T368; AccI was used for G-R385, G-E406, 
G-Q425, G-T434, and G-Q445; and HinclI was used for G-D464, G-D487, 
G-E501, G-I514, and G-M543 (see Fig. 1 B). 
The deletion of putative COOH-terminal transmembrane domains was 
introduced into the fusion proteins by overlapping extension PCR (Higu- 
chi et al., 1988). Amplified fragments containing the desired deletions cor- 
responding to GLAST-1 amino acid residues 345-354, 389-397, 407-416, 
and 488-494 were digested with AccI and XhoI present in the undeleted 
fusion protein sequences to obtain DNA cassettes, which were exchanged 
for the respective wild-type cassettes of G-R385, G-E406, G-Q425, G-E501, 
and G-M543. This resulted in the cDNA chimeras coding for AG-R385 
(A345-354),  AG-E406  (A389-397),  AG-Q425  (A407-416),  AG-E501 
(A488-494), and AG-M543 (A488--494) (see Fig. 1 C). All constructs were 
characterized by restriction enzyme analysis and DNA sequencing. 
Insertion  of Glycosylation Sites and Single Substitutions 
Unique N-glycosylation sites (consensus sequence N/X/T or N/X/S; Hart 
et al., 1978) were introduced into the GLAST-1 gene of pSP64-GLAST at 
position 1143 and 1303 by overlapping extension PCR. The replacement 
of the sequences GTG and GCC by ACG and AAC led to the single- 
amino acid substitutions T382V and N435A. The PCR fragments contain- 
ing the desired mutations were cut with KpnI and HincII and inserted into 
the GLAST-1 gene, replacing the respective wild-type cassette. The mu- 
tant transporters G-T382V and G-N435A were obtained. 
The mutant transporters G-EL389FV, G-T382V/EL389FV, and G-T382V/ 
VSV were constructed by site-directed mutagenesis. An Xhol site was 
introduced into wild-type GLAST-1 and the mutant transporter G-T382V 
by the same strategy as for the insertion of N-glycosylation sites. The re- 
placement of TTTGTG by CTCGAG at position 1164 corresponds to the 
amino acid substitutions E389F  and  L390V and resulted in  cDNAs of 
G-EL389FV  and  G-T382V/EL389FV.  Sense  and  antisense oligonucle- 
otides encoding the COOH terminus (YTDIEMNRLGK) of the vesicular 
stomatitis virus G protein (VSV) (Kreis, 1986) were synthesized to insert 
an extension peptide at the COOH terminus of residue L390 in G-T382V/ 
EL389FV.  The  annealed  double-stranded  oligonucleotides  flanked  by 
sticky-ended XhoI sites were phosphorylated with T4-polynucleotide ki- 
nase (Boehringer Mannheim Corp.) and cloned into the engineered Xhol 
site, resulting in G-T382V/VSV. All mutations and subcloned nucleotide 
sequences were verified by DNA sequencing. 
RNA Transcription 
Plasmids were linearized with EcoRl. The respective methyl-diguanosine- 
triphosphate-capped cRNAs were synthesized from their corresponding 
[inearized templates using SP6 RNA polymerase (Boehringer Mannheim 
Corp.)  following standard  methods (Colman,  1984).  RNA quality  was 
checked by electrophoresis in formaldehyde (1.2%) agarose gel. 
Cell-free Translation and Deglycosylation 
In vitro synthesized cRNA (300-500 ng) was translated in micrococcal nu- 
clease-treated rabbit reticulocyte lysate (amino acid depleted; Amersham 
Corp., Arlington Heights, IL) in the presence of canine pancreatic rough 
microsomal membranes (Boehringer Mannheim Corp.) according to the 
supplier's instructions. The reaction mixture (25 ~l total volume) with op- 
timal translation efficiency contained 1,110  kBq [35S]methionine (Amer- 
sham Corp.), 25 IxM of each amino acid except methionine, 100 mM po- 
tassium acetate, and 2 mM magnesium acetate and was incubated at 30°C 
for 60 min. 
After addition of 25 ~1 STPM (0.25 M sucrose, 50 mM triethanolamine, 
140 mM potassium acetate, and 2.5 mM magnesium acetate) membranes 
were  pelleted  by ultracentrifugation for  10  min  and  rinsed with  50  ~1 
STPM.  One  aliquot was resuspended in 50  ~1 Laemmli sample buffer 
(62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 5% mercaptoethanol, 1% SDS, 
and 0.04% bromophenol blue) and the other in 25 ~1 0.75% Triton X-100, 
30 mM Tris-HCl, pH 8, for deglycosylation with endoglycosidase F (Endo F; 
50 mU) (Boehringer Mannheim Corp.) for 1 h at 37°C. The reaction was 
terminated by the addition of 25 ixl 2x Laemmli sample buffer. Proteins 
were analyzed by SDS-PAGE (Laemmli, 1970) followed by fluorography 
(Laskey and Mills, 1975). 
Alkaline Extraction 
The pH of the in vitro translation assay, carried out in the presence of 
rough microsomal membranes, was adjusted to 11.5  by the addition of 
25 ixl of carbonate buffer (50 mM potassium acetate, 100 mM Na2CO  3, 
20  mM triethanolamine, and  I  mM magnesium acetate).  The  reaction 
mixture was stored on ice for 20 rain and layered over 20 IM STPM con- 
taining 100 mM Na2CO3.  Microsomes were sedimented at 49,000 rpm at 
4°C for 20 min. The pellet was washed with 25 ~l STPM and dissolved in 
30/.d Laemmli sample buffer. The supernatant was neutralized with 10 ~l 
acetic acid and proteins were precipitated with two volumes of saturated 
ammonium sulfate for 30 rain at 0°C, sedimented at 14,000 rpm, 4°C for 10 
rain. The pellet was washed with 5% trichloroacetic acid and dissolved in 
50 ~l Laemmli sample buffer for SDS-PAGE. 
Expression  in Oocytes, Immunoprecipitations,  and 
Glycosidase Treatment 
Stage V-VI oocytes were defolliculated with collagenase and injected with 
40 nl of cRNA of mutant GLAST-1 construct (0.5  mg/ml) (Storck  et al., 
1992).  Oocytes  were  incubated  in  Barth's  modified  saline  containing 
[35S]methionine (2.5 mCi/ml) for 24 h. Deglycosylation with Endo F and 
immunoprecipitation with polyclonal GLAST-1 antibody was performed 
as previously described (Conradt et al., 1995).  Translation products were 
analyzed by SDS-PAGE (Laemmli, 1970) followed by fluorography (Las- 
key and Mills, 1975). 
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Electrogenic  transport was assayed by voltage clamp using the two elec- 
trode voltage clamp amplifier (Warner Instruments Corp., Hamden, CT; 
hardware  and software package  ISO2 from MFK, Frankfurt,  Germany). 
Briefly, oocytes were voltage clamped at -90 mV and continuously super- 
fused with Barth's modified saline. Microelectrodes  filled with 3 M KCI 
had a resistance ranging from 1-2 Mfl. 
Immunofluorescence Microscopy 
Preparation of oocyte frozen thin sections and immunofluorescence  mi- 
croscopy on the fusion proteins and mutant transporters were carried out 
as described previously (Conradt and Stoffel, 1995). 
For immunofluorescence  on  HEK293  cells, permanently expressing 
GLAST-I (Blau and Stoffel, 1995) cells were grown on coverslips, rinsed 
with PBS, fixed with 2%  paraformaldehyde  in PBS for 15 min at room 
temperature (RT),  permeabilized  with 0.25% Triton  X-100 in PBS for 5 
min at RT, blocked with 5% BSA in PBS for 1 h at RT, incubated  with 
primary antibodies  in PBS containing 2% BSA for 3 h at RT, incubated 
with secondary antibody in PBS containing 2% BSA, and then mounted 
with use of glycerol gelatine (Merck, Darmstadt, Germany). 
The primary  antibodies  were affinity-purified  rabbit anti-GLAST-1 
antibody (Storck et al., 1992), monoclonal mouse anti-ct-tubulin antibody 
(Sigma Chemical Co., St. Louis, MO), and polyclonal rabbit  anti-P24-40 
antibody.  Secondary  antibodies  were FITC-conjugated  goat  anti-rabbit/ 
anti-mouse IgG and Cy3-conjugated sheep anti-rabbit IgG (Sigma Chem- 
ical Co.). 
Stained cells and frozen thin sections of oocytes were visualized with a 
fluorescence  microscope  (Axiophot;  Carl  Zeiss,  Inc., Thornwood, NY) 
equipped with fluorescein and Cy3 optics and photographed with a micro- 
scope camera (model MC 100; Carl Zeiss, Inc.). 
Polyclonal Antipeptide Antibody 
The synthetic peptide corresponding  to the NH2-terminal residues 24-40 
of rat GLAST-1  protein (KRTLLAKKKVQNITKED) was synthesized 
on a peptide synthesizer (model 433A; Applied Biosystems, Inc., Foster 
City,  CA)  following  the manufacturer's instructions.  The  peptide was 
characterized by reversed phase high performance liquid chromatography 
and sequencing.  It was coupled  to keyhole  limpet  hemocyanin  (Sigma 
Chemical Co.) (Goodfriend et al., 1964). 400 I~1 protein-peptide  conjugate 
in PBS (300 jxg peptide) was emulsified with an equal volume of complete 
Freund's adjuvant and injected intramuscularly  in a New Zealand White 
rabbit.  For booster immunizations  (2-wk intervals), Freund's incomplete 
adjuvant and half the amount of antigen were used. The rabbit was bled 
10 wk after the first immunization. 
The  antibody  was  characterized  against  a  purified  preparation  of 
GLAST-1 protein (Western blot) and chimeric protein G-E77 by immu- 
noprecipitation.  For affinity purification  (Catty, 1988), the synthetic pep- 
tide was coupled to ethylaminohexyl Sepharose 4B (Pharmacia LKB Bio- 
technology, Piscataway, N  J). Ethylaminohexyl-Sepharose  (30 i~mol active 
amino groups) was incubated with 10 mg peptide and 90 ~mol N-ethoxy- 
carbonyl-2-ethoxy-l,2-dihydroquinoline  (Sigma  Chemical  Co.)  in  6  ml 
50% ethanol overnight at RT. The column material was rinsed three times 
with 50, 100, 50, and 20% ethanol, blocked with 0.2 M glycine, pH 8, for 2 h 
at RT and washed with PBS. l0 ml antiserum was recircled over the affin- 
ity column for 2 h. Unspecific bounded proteins were disrupted  by wash- 
ing with 10 mM Tris-HC1, pH 7.5, 0.5 M NaC1. Specific antibodies  were 
eluted with 0.2 M glycine-HC1,  pH 2.5, neutralized with 1 M Tris-HC1, pH 
8, and dialyzed against PBS for 3 d. 
Results 
Chimeras with a Glycosylation Reporter Probe the 
Sidedness of Membrane Integration of GLAST-1 
Our goal was to identify which of the hydrophobic protein 
segments actually span the membrane (TMDs) and to de- 
termine the cellular orientation of the membrane-flanking 
EMRs. We mapped the luminal or cytoplasmic orienta- 
tion of the intervening hydrophilic loops with an endoge- 
nous  reporter of translocation.  It was  fused in frame to 
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Figure 1.  (A) Hydropathy plot of GLAST-1. The Kyte-Doolittle 
method with a  window of 10  amino acids was applied. Six ex- 
tended hydrophobic regions are located in the NH2-terminal part 
of GLAST-1  (M1-P345)  corresponding to  the predicted trans- 
membrane domains TMD1-TMD6. At least seven short, moder- 
ately hydrophobic segments are indicated in the COOH-terminal 
part. (B) Schematic model of the GLAST-1 transporter. Endoge- 
nous N-glycosylation sites are indicated by "trees." Boxes labeled 
with TMD denote topogenic hydrophobic regions as indicated by 
the present study. Identified hydrophilic EMRs are marked  as 
EMR1-EMRll. The vertical lines below the solid heavy line in- 
dicate the COOH termini of NHz-terminal GLAST-1 fragments, 
to which the glycosylation reporter was fused. The vertical lines 
above  indicate the  positions of substituted  amino  acids  intro- 
duced either to generate additional N-glycosylation sites in the 
primary sequence (T382V, N435A) or to insert the VSV extension 
peptide of 11 amino acids into GLAST-1 (EL389FV). (C) Sche- 
matic presentation of GLAST-1  deletion chimeras. Membrane- 
spanning regions are numbered and marked by empty squares. A 
57-amino acid N-glycosylation reporter derived from EMR4 of 
GLAST-1 was fused in frame to truncated GLAST-1 sequences. 
The  deletion chimeras each lack  the ultimate  COOH-terminal 
transmembrane domain of the corresponding undeleted chimeras 
with identical fusion points. 
NHz-terminal  parts  of  GLAST-1,  truncating  the  trans- 
porter at various positions in the extramembrane regions 
(Fig. 1 B). This 57-residue N-glycosylation reporter was 
derived from the large extracellular hydrophilic loop of 
GLAST-1 (D172-R228), which contained the two genuine 
transporter  N-glycosylation  sites  at  N206  and  N216 
(Conradt et al.,  1995; Schulte and Stoffel, 1995).  This re- 
porter sequence is considered to be devoid of any target- 
ing information, which might interfere with its transloca- 
tion across the membrane.  The cRNAs  of the  chimeras 
were expressed in the presence of [35S]methionine in vitro 
in  reticulocyte lysates with rough microsomes and upon 
microinjection  in  Xenopus oocytes.  The  glycosylated 
Wahle and Stoffel Membrane Topology of L-Glutamate Transporter  1869 translation  products  were  immunoprecipitated  and  ana- 
lyzed by SDS-PAGE and fluorography. The orientation of 
the polypeptides integrated into the ER membrane is in- 
verted from that  in  the plasma membrane. Bi-antennary 
N-glycosylation of the  reporter  sequence  proved by the 
mobility shift in SDS-PAGE after digestion with Endo F 
characterized chimeras with the reporter protruding into 
the lumen of the ER. This corresponds to an extracellular 
orientation  of  the  attached  hydrophilic  region  in  the 
plasma membrane; the absence of reporter glycosylation is 
indicative of its intracellular orientation. 
Topology of the Six Hydrophobic Segments of the 
NH2-  Terminal Domain 
The hydropathy plot of GLAST-1 (Fig. 1 A) clearly subdi- 
vides the protein into two large domains. In contrast to the 
extended  moderately  hydrophobic  stretch  (amino  acids 
345-500) near the COOH terminus of the transporter, the 
NH~-terminal domain  of nearly 345  amino acids  has  six 
distinct  hydrophobic domains 20 to 23 residues in length 
(TMD1-TMD6 in Fig. 1 B), bordered by charged residues. 
They have been previously predicted to form transmem- 
brane a-helices. They are connected by six hydrophilic ex- 
tramembrane regions  (EMR2-EMR7),  to each  of which 
the  N-glycosylation reporter was fused at positions  indi- 
cated in Fig. 1 B.  Corresponding results were obtained in 
both  expression  systems.  N-glycosylation  was  detected 
only of the  reporters  linked  to  residues  E77,  P233,  and 
Q313. Chimera G-E77, truncating the transporter sequence 
at E77 in EMR2, yielded a bi-antennary glycosylated poly- 
peptide as evidenced by the 6-kD mobility shift after Endo F 
treatment (Fig. 2 A, lane 1-4). Fusion proteins G-P233 and 
G-Q313  tagging EMR4  and EMR6  (Fig.  2 A, lane 9-12; 
Fig. 2 B, lane 5-8) were fourfold glycosylated, twice at the 
reporter and at both genuine GLAST-1 glycosylation sites 
(N206  and  N216).  When  digested  with  Endo  F,  protein 
size decreased for ~12 kD. On the other hand, N-glycosy- 
lation  was  not  observed  for  reporters  fused  to  EMR3, 
EMR5,  or  EMR7.  The  apparent molecular mass of chi- 
mera G-R122 (Fig. 2 A, lane 5-8) remained unchanged af- 
ter enzymatic deglycosylation. The  predominant  transla- 
tion product of chimeras G-$273 (Fig. 2 B, lane 1-4) and 
G-N344 (Fig. 2 B, lane 9-12) exhibited only a 6-kD mobil- 
ity shift and were thus only twofold glycosylated at genu- 
ine  GLAST-1  consensus  sites.  In  the  case  of  in  vitro- 
expressed G-$273,  an insignificant  amount of three- and 
fourfold glycosylated polypeptides is  visible (both  upper 
bands in Fig. 2 B, lane 1). A  phenomenon we observed for 
most of the  in vitro translations  performed in  this  study 
was  the  appearance  of a  signal  representing  unglycosy- 
lated and thus unprocessed protein. This is almost absent 
in the oocyte experiments. Furthermore, all six fusion pro- 
teins were found to be integrated into the lipid bilayer of 
microsomal membranes by the criterion of nonextractabil- 
ity  with  sodium  carbonate  at  alkaline  pH  (Fujiki  et  al., 
1982; Russel and Model, 1982)  (data not shown). 
We conclude from these results that the hydrophilic se- 
quences EMR2, EMR4, and EMR6 are exposed to the ex- 
tracellular, EMR3, EMR5, and EMR7 to the cytosolic sur- 
face of the  plasma membrane. Each  of the  hydrophobic 
segments in  the NH~-terminal part of GLAST-1  is sand- 
wiched  between  an extracellular  and  intracellular  region 
indicating six TMDs. TMD1, TMD3, and TMD5 span the 
plasma membrane from the intracellular to the extracellu- 
lar surface, and TMD2, TMD4, and TMD6 span with re- 
verse orientation. 
Membrane Topology of the Conserved COOH-Terminal 
Domain of GLAST-1 
Previous  models of three  L-glutamate transporters  have 
proposed two (GLT-1), four (EAAC-1), or six (GLAST-1) 
hydrophobic domains spanning the plasma membrane in 
the highly conserved COOH-terminal domain, albeit the 
hydropathy blot is too ambiguous for a  reliable structure 
prediction.  12  additional  reporter chimeras step-wise ex- 
tended  the  NH2-terminal domain of GLAST-1 by 10-29 
Figure 2.  Analysis of the topology of the NH2-terminal part of GLAST-I. N-glycosylation and membrane integration  of chimeras with 
the reporter fused at sites located within the NHz-terminal domain of GLAST-I: (A and B) GLAST-1 reporter hybrids were translated 
in the rabbit reticulocyte lysate system in the presence of microsomal membranes and upon microinjection  in Xenopus oocytes. Transla- 
tion products were isolated by ultracentrifugation  of the microsomal membranes (in vitro) or by immunoprecipitation  with a polyclonal 
GLAST-1 antibody from the oocyte lysate in the in vivo experiment.  Proteins were separated by SDS-PAGE (10-15%) and visualized 
by fluorography (see Materials and Methods).  Concordant results were obtained in both expression systems used. Treatment with Endo 
F reduced the apparent molecular mass of chimeras G-P233 and G-Q313 by ~12 kD, and of G-E77, G-$273, and G-N344 by ~6 kD. No 
mobility shift was observed in the case of G-R122. 
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terminus of TMD6 up to M543 (see Fig. 1 B). When trans- 
lated in both expression systems, chimeras G-E406 (Fig. 
3 B, lanes 1-4), G-E501, G-I514, and G-M543 (Fig. 3 D, 
lanes 1-12) exhibited only a 6-kD mobility shift after Endo F 
treatment monitoring nonmodified reporter sites. We con- 
clude that the short hydrophilic region around residue E406 
(EMR9 in Fig. 1 B) as well as the highly charged COOH 
terminus of GLAST-1  (residues E501-M543;  EMRll  in 
Fig. 1 B) are exposed on the cytoplasmic side of the ER or 
plasma membrane. 
Unexpectedly, in  vitro and  in  vivo translation  of chi- 
meras G-Q354, G-T368, G-R385, (Fig. 3 A, lanes 1-12), 
G-Q425, G-T434 (Fig. 3 B, lanes 5-12), G-Q445, G-D464, 
and G-D487 (Fig. 3  C, lanes 1-12) generated two differ- 
ently glycosylated polypeptides of approximately equal in- 
tensity in autoradiography. Endo F reduced their apparent 
molecular mass by roughly 12 and 6 kD and resulted in a 
single band of deglycosylation product. The weak signals 
in the in vitro translations of G-T368 and G-R385 (Fig. 3 A, 
lanes 5 and 9) represent trace amounts of one- and three- 
fold glycosylated polypeptides. However, these results in- 
dicated that the reporter of nearly one half (40-55%) of 
each  expressed  chimeric protein  was  fully glycosylated, 
yielding a  tetra-antennary glycoprotein with the COOH- 
terminal  reporter protruding  into  the  lumen  of the  ER 
(upper band in Fig. 3, A  and C, lanes 1, 3, 5, 7, 9, and 11; 
Fig. 3 B, lanes 5, 7, 9, and 11). The reporter of the rest of 
the integrated  polypeptides remained  unglycosylated on 
the cytoplasmic side of the membrane represented by bi- 
antennary  glycoprotein. Reflecting  the  random  orienta- 
tion of the reporter, this glycosylation pattern seemed to 
be  devoid of any topological information.  Nevertheless, 
we obtained evidence to indicate the lumenal localization 
of the tagged EMRs from the following experiment. 
A  third N-glycosylation signal at N380 (G-T382V) and 
N435 (G-N435A) was introduced in wild-type GLAST-1 
using site-directed mutagenesis (see Fig.  1 B). Tri-anten- 
nary glycosylation would probe the lumenal/extracellular 
orientation of the new consensus sites in membrane-inte- 
grated  GLAST-1.  However,  polypetides  synthesized  in 
Xenopus oocytes from G-T382V and G-N435A cRNAs had 
the same size as the wild-type transporter. Enzymatic de- 
glycosylation reduced the molecular mass  from 60--63 to 
54-57 kD (Fig. 4, lanes 1-6). N-glycosylation of the engi- 
neered consensus sites should fail if they are located in the 
cytosolic compartment or if their close proximity to the lu- 
menal membrane surface prevents access for the N-glyco- 
sylation machinery. We favored the second possibility and 
extended the short distance between residue N380 and the 
Figure 3.  Analysis of the topology of the COOH-terminal part of GLAST-1. N-glycosylation  and membrane integration of in vitro- and 
in vivo-translated chimeras with the reporter fused at sites located within the COOH-terminal  domain of GLAST-I: (A-D) Protein ex- 
pression, deglycosylation, and sample analysis was performed as described in Fig. 2. The chimeras G-E406, G-E501, G-I514, and 
G-M543 were twofold glycosylated  as indicated by their reduced apparent molecular mass of ~6 kD after treatment with Endo F. Note 
that chimeras G-Q354, G-T368, G-R385, G-Q425, G-T434, G-Q445, G-D464, and G-D487 showed a random distribution  of bi- and 
tetra-antennary glycosylated translation products, indicated by their apparent SDS-PAGE mobility shifts relative to the deglycosylated 
proteins of ~6 and 12 kD, respectively. 
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COOH-terminal amino acids of the VSV glycoprotein (Kreis 
et al., 1986). The two-step cDNA synthesis (see Materials 
and Methods)  yielded two different transporter mutants. 
The  intermediate  construct  G-T382V/EL389FV  carried 
the amino acid substitutions E389F and L390V, G-T382V! 
VSV in  addition  to the VSV extension peptide (see also 
Fig. 1 B). Xenopus oocytes microinjected with the respec- 
tive cRNAs generated threefold glycosylated polypeptides 
(Fig. 4, lanes 7-10). The apparent molecular mass of N63- 
66 kD exceeded by ~3 kD that of the mutant G-EL389FV, 
which lacked the engineered N-glycosylation site at N380 
(Fig.  4,  lanes  11-12),  and  was  reduced  to  54-56  kD  by 
Endo F treatment. These findings provide strong evidence 
for  the  lumenal  orientation  of  the  hydrophilic  region 
around residue N380 (EMR8 in Fig. 1 B). Because the fu- 
sion point of the chimera G-R385 was also located in this 
domain, we interpret  its random bi- and  tetra-antennary 
glycosylation in strong support of the extracellular orien- 
tation of respective reporter-attached residues located in 
the  COOH-terminal domain of GLAST-1 (residues 345- 
543). We had observed the same glycosylation pattern for 
chimeras with the reporter linked to residues Q354, T368, 
and  R385,  as  well  as  to  Q425,  T434,  Q445,  D464,  and 
D487,  and  therefore  suggest  two  additional  extramem- 
brane  regions,  EMR8  and  EMR10,  on  the  extracellular 
surface of the  plasma membrane (Fig.  1 B).  Keeping in 
mind  the  cytosolic  placement  of  EMR7,  EMR9,  and 
EMRll, the alternating cytosolic and extracellular orien- 
tation of the five identified extramembrane regions EMR7- 
EMRll  demands  four  hydrophobic  transmembrane  do- 
mains (TMD7-TMD10)  spanning the plasma membrane 
in the COOH-terminal part of GLAST-1. 
Deletion of Transmembrane Segments in the 
COOH-terminal Domain of GLAST-1 
The hydropathy plot (Fig. 1 A) of the four COOH-termi- 
nal TMDs identified by the experiments described above 
suggests short hydrophobic segments of 7-10 residues. To 
confirm their topogenic activity, we deleted each of these 
segments and examined the effect of this manipulation on 
the  glycosylation reporter  fused  COOH-terminal  to  the 
respective TMD (Fig. 1 C). It is expected that an extracel- 
lular location  of the  fusion site of chimeras with the  re- 
porter linked to TMD7 and TMD9, being randomly two- 
and fourfold glycosylated, will switch to the intracellular 
surface in  the  deletion  mutant,  thus  preventing reporter 
glycosylation. We synthesized the deletion chimeras AG- 
R385 (A P345-Q354) and AG-Q425 (A A407-V416) in the 
in vitro and in vivo system. The size of the single glycosy- 
lated translation product was reduced by 6 kD after Endo 
F  treatment (Fig. 5 A, lanes 1-8). This indicated that the 
reporter remained unglycosylated on the cytosolic side of 
the  membrane.  To  show  that  deletion  of  TMD8  and 
TMD10 also changes the glycosylation pattern of the re- 
porter fused COOH-terminal to these TMDs, we excised 
residues F389-I397 in chimera G-E406 and residues $488- 
V494 in G-E501 and G-M543 (Fig. 1 C). Unlike the unde- 
Figure 4.  N-glycosylation  of wild-type  and  mutant  GLAST-1 
proteins expressed in Xenopus oocytes.  Protein expression,  de- 
glycosylation,  immunoprecipitation, and  sample  analysis  were 
carried out as described in Fig. 2. The equal SDS-PAGE mobility 
shifts of mutants G-T382V and G-N435A of,-,~6  kD after treatment 
with Endo F as compared with wild-type GLAST-1 indicated  a 
twofold glycosylation of the proteins. The apparent molecular mass 
of constructs G-T382V/EL389FV and G-T382V/VSV exceeded that 
of G-EL389FV  by ~3 kD, indicating  threefold glycosylation of 
both mutants. 
Figure 5.  N-gtycosylation  of in  vitro- and in  vivo-synthesized 
chimeric GLAST-1 proteins with the deletion of TMD7, TMD8, 
TMD9, or TMD10. Protein expression, deglycosylation, and sam- 
ple analysis were performed as described  in Fig. 2. (A) The ap- 
parent molecular masses of deletion mutants AG-R385 and AG- 
Q425 were shifted  after deglycosylation  to a molecular mass re- 
duced  by ~6 kD, which  revealed a  bi-antennary glycosylation 
only compared to the respective undeleted GLAST-1 constructs 
with their random tetra- and bi-antennary glycosylation (see Fig. 
3, A  and B). (B) The reporter of AG-E501 is partially glycosy- 
lated in  both expression  systems  as demonstrated by the  two 
bands with different mobilities. The same observation was made 
for in vitro-synthesized AG-E406. Note that AG-E406 expressed 
in the oocyte, as well as AG-M543 in both expression  systems, 
showed  only one signal of a twofold  glycosylated  protein indi- 
cated by the 6-kD shift like in the undeleted chimeras (see Fig. 3). 
No glycosylation of the reporter sites had occurred. 
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the deletion chimera AG-E406 translated in the reticulo- 
cyte lysate and AG-E501 regardless of the expression sys- 
tem used showed the expected random bi- and tetra-anten- 
nary glycosylation (Fig. 5 B, lanes 1 and 2 and 5--8; compare 
Fig. 3 B, lanes I  and 2, and 3 D, lanes 1-4). This glycosyla- 
tion pattern indicates the extracellular orientation of the 
fusion points, which had switched from the intracellular to 
extracellular side. AG-E406 synthesized in the oocyte car- 
ried  only two carbohydrate chains  at  endogenous N206 
and N216, like the undeleted fusion protein (Fig. 5 B, lanes 
3 and 4; compare Fig. 3 B, lanes 3 and 4). The upper band 
in lane 4 of Fig. 5 B reflects incomplete enzymatic deglyco- 
sylation. Unexpectedly, the deletion of TMD10 in the chi- 
mera G-M543 did not invert the cytosolic orientation of 
the fusion point (Fig. 5 B, lanes 9-12; compare Fig. 3 D, 
lanes 9-12). These results prove that the deleted hydro- 
phobic segments P345-Q354, A407-V416, and $488-V494 
are  core sequences of the  membrane-spanning  domains 
TMD7,  TMD9,  and  TMD10.  The  topogenic activity of 
TMD8 (F389-I397) could not be concluded with certainty 
from these experiments. 
GLAST-1 Fusion Proteins Are Correctly Targeted to the 
Plasma Membrane but Inactive Transporters 
The impact of the truncation and COOH-terminal tagging 
by a reporter sequence of GLAST-1 on the electrogenic, 
Na+-dependent  L-glutamate transport function was  ana- 
lyzed with the whole cell voltage clamp technique in Xenopus 
oocytes expressing the respective transporter cRNAs. The 
inward current of oocytes synthesizing the different chime- 
ras was measured at 100 IxM L-glutamate and 90 mM so- 
dium [Na +] extracellular concentrations as previously de- 
scribed (Kl6ckner et al., 1993). Neither wild-type GLAST-1 
linked to the N-glycosylation reporter (G-M543) nor any 
of the other fusion proteins showed any neurotransmitter 
transport activity (data not shown). The loss of function 
could either be due to a reduced expression level, to a re- 
duced stability of the mutant transporters, to an impaired 
targeting to the plasma membrane, or to the COOH-ter- 
minal truncation of GLAST-1 and tagging by the reporter 
sequence. Comparable intensities of the [35S]methionine- 
labeled  and  immunoprecipitated translation  products  of 
GLAST-1 (Fig. 4, lanes I  and 2) and chimeric transporters 
(Figs. 2 and 3) expressed in Xenopus oocytes ruled out the 
first possibility. The correct targeting to the plasma mem- 
brane of Xenopus oocytes was traced by immunofluores- 
cence microscopy. Oocytes expressing wild-type GLAST-1 
and the chimeras G-M543 and G-N344 were strongly la- 
beled along their perimeter by GLAST-1 antibodies and 
fluorescent second antibodies (Fig. 6 A, 2, 3, and 4), con- 
sistent with the localization of the hybrid transporters at 
or close to the cell surface. Identical results were observed 
for all of the other chimeras with the fusion point between 
residue N344 and M543 (data not shown). In the case of 
water-injected control oocytes, no fluorescence was  ob- 
served (Fig. 6 A, 1). We conclude that the deletion of indi- 
vidual  COOH-terminal  sequences  and/or the  fusion  of 
the reporter to the  COOH  terminus of full-length wild- 
type GLAST-1 (M543) or truncated GLAST-1 polypeptides 
abolish  the  glutamate  transport  properties  of  the  ex- 
pressed  membrane-integrated glycoproteins. It should be 
noted that the point mutations in the transporter G-T382V/ 
EL389FV, which was  fully glycosylated at residue N380 
and in G-EL389FV, which lacks the engineered N-glycosy- 
lation consensus site, also lead to a  complete loss of the 
glutamate transport activity (data not shown). Both mu- 
tants  are  normally expressed  (Fig.  4,  lanes  9-12) and 
correctly targeted to the plasma membrane (Fig. 6 A, 5 
and 6). In contrast, the functional properties of the mu- 
tated transporter G-T382V are comparable to wild-type 
GLAST-1 (data not shown) (Kl6ekner et al., 1993).  This 
underlines the substantial influence of the amino acid sub- 
stitution  E389F combined with  the  exchange L389V on 
the activity of GLAST-1. 
The NHz Terminus of GLAST-1 Is Exposed to 
the Cytosol 
The orientation of the NH2 terminus (EMR1 in Fig. 1 B) 
of GLAST-1 was  examined by indirect immunofluores- 
cence epitope mapping in a  HEK cell line, permanently 
expressing wild-type GLAST-1 (HEK-GLAST) (Blau and 
Stoffel, 1995).  If the first extramembrane region EMR1 is 
located in the cytoplasm, this domain should be accessible 
for a specific antibody only after permeabilization of the 
plasma membrane. 
Affinity-purified antibodies  raised  against  a  synthetic 
peptide comprising residues 24--40 (P24--40) of GLAST-1 
were generated. Only permeabilized HEK-GLAST cells 
were strongly labeled by immunofluorescence by these im- 
munoglobulines (Fig. 6 B, 3 and 6). Therefore the NH2 ter- 
minus (EMR1) of GLAST-1 must be exposed to the cyto- 
solic surface of the plasma membrane. 
Fig. 6 B also visualizes the results of the control experi- 
ments. Intact HEK-GLAST cells were labeled with poly- 
clonal rabbit anti-GLAST-t antibodies (Storck et al., 1992), 
which also recognized extracellular transporter epitopes, 
and were impermeable for mAbs raised against a-tubulin. 
Permeabilization of cells with Triton X-100 was required 
to allow labeling with specific antisera against both a-tubu- 
lin and GLAST-1. Untransfected wild-type HEK cells showed 
no reaction with GLAST-1 antibodies (data not shown). 
Discussion 
We applied "reporter glycosylation scanning" to establish 
the complete topology of GLAST-1 in the plasma mem- 
brane. The localization of hydrophilic extramembrane re- 
gions was mapped to determine the number and orienta- 
tion  of membrane-spanning  domains.  We  provide  here 
experimental evidence for six presumably a-helical trans- 
membrane domains in the NH2-terminal part of GLAST-1, 
flanked  by  seven  hydrophilic  extramembrane  regions. 
Fourfold glycosylated chimeras with a lumenal reporter in- 
dicated the inside-out orientation (cytosolic to extracellu- 
lar) of TMD1, TMD3, and TMD5, and the twofold glyco- 
sylation of fusion proteins probed the reverse orientation 
of TMD2, TMD4, and TMD6. The specific fourfold gly- 
cosylation of chimeras G-P233 and G-Q313 proved that the 
reporter sequence placed at the COOH terminus of trun- 
cated GLAST-1 polypeptides is readily translocated across 
the ER membrane. The efficient N-glycosylation makes the 
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in the cytoplasm. (A) Cryosections (15-20 ixm) of Xenopus oocytes were incubated with anti-GLAST-1 antibody and stained with fluo- 
rescein isothiocyanate-conjugated second antibody. Wild-type GLAST-1 (2), G-M543 (3), G-N344 (4), G-EL389FV (5), and G-T382V/ 
EL389FV (6) were expressed and targeted to the surface of oocytes with similar intensity. In the case of water-injected  control oocytes 
(1), no fluorescence  labeling was observed.  (B) HEK 293 cells, permanently expressing wild-type GLAST-1, were immunostained with 
(4-6) and without  (1-3) permeabilization of the plasma membrane (Triton X-100) as described  under Materials  and Methods.  Cells 
were either doubly labeled with mouse monoclonal antitubulin  and rabbit polyclonal anti-GLAST-1 antibodies  (1 and 2, 4 and 5) or la- 
beled with rabbit polyclonal P24-40 antibodies  (3 and 6). Second antibodies  were fluorescein-anti-mouse IgG (1 and 4), fluorescein- 
anti-rabbit IgG (3 and 6) and cy3-anti-rabbit IgG (2 and 5). Staining of the cytosolic tubulin was only observed after disruption of mem- 
brane structures with Triton X-100 (4). Labeling of GLAST-1 at the cell surface was observed regardless of the integrity of the plasma 
membrane (2 and 5). The NH2 terminus of GLAST-1 was labeled with P24-40 antibodies only after permeabilization of the plasma 
membrane (6), indicating its cytosolic orientation.  Bar, 10 Ixm. 
reporter sequence a reliable indicator of the extracellular 
or cytoplasmic sidedness of the tagged hydrophilic loops. 
Consistent with cell surface immunostaining of oocytes ex- 
pressing G-N344 and G-M543, the reporter has no substan- 
tial influence on the folding of the transporter. Misfolded 
proteins  would  be retained  in  the  biosynthetic compart- 
ments and  then  rapidly degraded.  The signal  for protein 
targeting from the ER via Golgi to the plasma membrane 
seems to be present within the  NH2-terminal 344-amino 
acid sequence. Immunostaining of HEK cells permanently 
expressing GLAST-1 gave evidence for the cytosolic local- 
ization of the NH2 terminus (EMR1) of GLAST-1. This was 
expected from the absence of a cleavable signal sequence 
and from immunocytochemical labeling of astrocytes (Lehre 
et al., 1995).  Phosphorylation of Sl13 by protein kinase C 
in GLT-1 (Casado et al., 1993) also agrees with intracellu- 
lar localization of EMR3 connecting TMD2 and TMD3. 
The  extended,  moderately hydrophobic  COOH-termi- 
nal region of GLAST-1 is a feature uncommon for trans- 
porter proteins known so far. This domain is strongly con- 
served in the L-glutamate transporters GLAST-1, GLT-1, 
EAAC-1, and EAAT-4. The hydropathy plot exhibits at 
least  seven  short  hydrophobic  sequences  7-10  residues 
long  (Fig.  1  A),  implying that  membrane-spanning  seg- 
ments in this region might be of shorter length. Our exper- 
iments  with  undeleted  and  deleted  chimeras  identified 
four of them as the core of the transmembrane domains 
TMD7-10, which  are flanked by polar and  charged resi- 
dues. The topology of TMD8 could not be assigned with 
certainty by deleting residues F389-I397 in the fusion pro- 
tein  G-E406.  Reporter  inversion  in  the  deletion  mutant 
AG-E406 occurred only after in vitro translation but failed 
in the oocyte. We suggest that this might be due to an in- 
herent  topogenic activity keeping the  tagged  extramem- 
brane  region  EMR9  on  the  cytoplasmic side  of the  ER 
membrane in the oocyte. The same observation was made 
for the deletion chimera AG-M543 with the reporter fused 
to the COOH terminus of wild-type GLAST-1. Positively 
charged residues, accumulating here in the tagged hydro- 
philic region EMRll, are known as a dominant topogenic 
determinant, which may prevent translocation  of protein 
domains from the cytosol into the lumen of the ER (Boyd 
and Beckwith, 1989; von Heijne, 1989). 
The  shorter  extension  of TMD7  and  TMD9  as  com- 
pared  to  TMD1,  TMD3,  and  TMD5  is  likely to  be  re- 
flected in  the  different glycosylation pattern  of chimeras 
with the reporter sequence fused at the COOH terminus 
of inside-out-oriented  transmembrane domains. The ran- 
dom distribution  of bi- and  tetra-antennary glycosylated 
fusion proteins,  consistent  with  a  random orientation  of 
the  COOH-terminal  reporter to either side  of the  mem- 
brane,  might  be  explained  by  the  sequential  insertion 
The Journal of Cell Biology, Volume 135,  1996  1874 Figure 7.  Proposed GLAST-1 topology in the plasma membrane. Native N-glycosylation sites are indicated by arrow heads. Filled cir- 
cles mark the sites of GLAST-1, to which the reporter was fused, and arrows at residues 382 and 435 indicate the sites, that were mutated 
to obtain N-glycosylation mutants G-T382V, G-N435A, G-T382V/VSV, and G-T382V/EL389FV. The arrow at residues 389-390 points 
to the site where the ll-mer extension peptide was inserted. Exon boundaries are marked by roman numbers. Transmembrane domains, 
numbered TMDs 1-6, are likely to form tx-helices,  whereas TMDs 7-10 are considered to form B-sheets. 
mechanism proposed for type IV membrane proteins like 
GLAST-1  (Blobel,  1980;  Wessels  and  Spiess,  1988).  In 
analogy to the translocation of secretory proteins and in- 
sertion of type II membrane proteins (Shaw et al., 1988), 
we suggest that during the last insertion cycle of chimeric 
GLAST-1  protein,  the  ultimate  transmembrane  domain 
acting as a  signal anchor sequence and the translocating 
COOH-terminal portion of the growing polypeptide chain 
form a loop like structure in the proteinaceous (G6rlich et al., 
1992a, b; Mothes et al., 1994) and aqueous (Crowley et al., 
1993, 1994) translocation channel (ER translocase) across 
the ER-membrane, with the attached reporter remaining 
in the cytoplasm. The interactions of the traversing signal 
anchor sequence with the proteins of the ER translocase 
and the degree of the lateral opening of the channel to the 
lipid core vary presumably with its length and hydropho- 
bic properties (von Heijne, 1985, 1986; Nilsson et al., 1994; 
Martoglio et al., 1995). The efficient reporter glycosylation 
of chimeras  G-E77,  G-P233,  and  G-Q313  demonstrates 
that TMD1, TMD3, and TMD5, 20-23-hydrophobic resi- 
dues-long, are firmly anchored in the lipid bilayer. After 
chain  termination,  the  channel  opening  apparently  re- 
mains  wide enough  to  allow the  reporter to translocate 
into the ER lumen. If the reporter is linked to TMD7 or 
TMD9, its random orientation toward the cytoplasmic or 
the lumenal surface of the ER membrane might be caused 
by two reasons. Membrane integration of the TMD par- 
tially  fails  because  of  a  moderate  hydrophobicity and 
therefore reduced  interaction  with  the  lipids,  or  mem- 
brane integration takes place.but the narrow gated chan- 
nel imposes a steric hindrance to the translocation of the 
COOH-terminal reporter into the lumen of the ER. 
Since our experimental results combined with these con- 
siderations suggest shorter extensions of membrane span- 
ning TMD7-TMD10 other than a-helical structures must 
be considered. [3-Sheets  require 7-10-amino acid residues 
to  span  the  hydrophobic  core  of  a  membrane  bilayer 
(Schirmer and  Cowan,  1993).  Intrabilayer 13-sheet struc- 
tures  have  been  unequivocally  demonstrated  by  x-ray 
analysis in porins (Cowan et al., 1992) and have also been 
proposed to occur in the acetylcholine receptor (Akabas 
et al., 1992), in the VDAC ion channel (Blachly-Dyson et al., 
1990), and in lac permease (Radding, 1991). We propose 
13-sheet structures of the four COOH-terminal membrane- 
spanning regions of GLAST-1 but cannot rule out other 
conformations. Our experimental results and their inter- 
pretation fit best the membrane integration of GLAST-1 
depicted in Fig. 7. 
The topology profile proposed here facilitates the anal- 
ysis of specific GLAST-1 domains or single-amino  acid 
residues essential for neurotransmitter binding and trans- 
location. Aromatic residues border the ends of transmem- 
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(Y405; F412), similar to porins composed solely of a non- 
polar surface of 13-sheets buried in the lipid bilayer. Phe- 
nylalanine  residues  are  oriented  toward  the  lipid  core 
whereas  tyrosine  hydroxy  groups  and  tryptophan  side 
chains point toward the lipid polar headgr0ups (Weiss et al., 
1991; Cowan et al., 1992). The hydrophobic side chain of 
F389 of GLAST-1  is thought to be involved in the mem- 
brane anchorage of TMD8.  Substitution of F389 by E389 
combined with the conservative substitution L390V led to 
the  GLAST-1  mutant  transporters  G-T382V/EL389FV 
and G-EL389FV, which have lost glutamate transport ac- 
tivity. The negative charge of E389 might shift the trans- 
membrane segment TMD8 partially into an extracellular 
location.  The  distance  between  the  membrane  surface 
and  the  highly  charged  hydrophilic  region  surrounding 
residue N380 will thereby be enlarged and give access for 
the N-glycosylation machinery. This interpretation is con- 
sistent with the observation that N380 is only glycosylated 
in the triple mutant G-T382V/EL389FV, but not in the ac- 
tive single substitution  mutant  G-T382V  carrying the in- 
tact transmembrane domain TMD8. 
F389 is located in the most strongly conserved domain 
of  the  four  cloned  L-glutamate  transporters,  GLAST-1, 
GLT-1,  EAAC-1,  and  EAAT-4.  29  out  of  33  residues 
(amino  acids 383-415)  are  identical.  This sequence  con- 
tains  the  transmembrane  domains  TMD8  and  TMD9, 
which are joined by the short cytosolic loop EMR9. The 
adjacent side chains of Y405 and E406 in this EMR have 
recently  been recognized  to be  essential  for L-glutamate 
transport.  In  GLAST-1,  the  hydroxy  group  of  Y405  is 
thought  to  interact  with the  ~/-carboxylate  group  of the 
neurotransmitter  glutamate  passing  through  the  channel 
(Conradt and Stoffel, 1995). For GLT-1, the correspond- 
ing E404 has been suggested to line the glutamate/aspar- 
tate permeation pathway (Pines et al., 1995). The deduced 
cytosolic  localization  of both  residues  (Fig.  7)  excludes 
their direct participation in substrate binding but suggests 
an essential contribution to substrate translocation or dis- 
sociation on the inside of the plasma membrane. Further- 
more, the close neighborhood of residues Y405 and E406 
to  TMD8  and  TMD9  implies  that  both  transmembrane 
segments might directly contribute to the formation of the 
translocation pore. 
The topology model of GLAST-1 consisting of six mem- 
brane spanning a-helices and four shorter transmembrane 
domains  presumably  forming a  13-sheet cluster is unique 
and  defines  a new class  of transporter  proteins.  The as- 
sumption  that  clusters  of transmembrane  13-sheet struc- 
tures  are  involved  in  the  transport  of neurotransmitter 
substrate  will provide new dimensions for understanding 
the transport mechanism of the Na+-coupled high affinity 
L-glutamate  transporters.  The  highly  conserved  domain 
structure  of  all  L-glutamate  transporters  isolated  so  far 
suggests that the 10-TMD model of GLAST-1, deciphered 
by these studies experimentally,  might represent  a novel 
membrane topology of transporter molecules common to 
the other L-glutamate transporters GLT-1, EAAC-1,  and 
EAAT-4, and the neutral amino acid transporter ASCT-1. 
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